Close Menu
Fund Focus News
    Facebook X (Twitter) Instagram
    Trending
    • Is Invesco Diversified Dividend A (LCEAX) a Strong Mutual Fund Pick Right Now?
    • Sectoral mutual funds: Should you invest? Risks, returns and 5 things to consider before investing your money
    • 4 Utilities Mutual Fund Picks to Ride Rising Power Demand
    • 3 Balanced Mutual Funds to Buy for Long-Term Growth and Stability
    • The Nasdaq Just Entered a Correction. Are Your ETFs All Making the Same Bet?
    • AGF Investments Announces 2026 Estimated Annual Reinvested Capital Gains Distributions for ETFs
    • Why Are So Many Quality Funds Falling Behind?
    • ASOS Buys Back £90m of Convertible Bonds
    Facebook X (Twitter) Instagram
    Fund Focus News
    • Home
    • Bonds
    • ETFs
    • Funds
    • Investments
    • Mutual Funds
    • Property Investments
    • SIP
    Fund Focus News
    Home»ETFs»ETFs Are Net Sellers of AbbVie (ABBV) on Nov. 12
    ETFs

    ETFs Are Net Sellers of AbbVie (ABBV) on Nov. 12

    November 16, 2026


    This article first appeared on GuruFocus.

    SPY led the ETF selling in AbbVie (ABBV) on Thursday, as ETF activity produced a net outflow of $62.0 million. More funds traded the other way 40 ETFs bought while 16 sold but in smaller amounts. The move followed two straight days of net buying, with $68.8 million added on Nov. 11 and $33.5 million on Nov. 10. Before that, ETFs were net sellers of $4.3 million on Nov. 9 and $5.6 million on Nov. 6.

    Every ETF and guru trade in ABBV is tracked on the ABBV guru trades page.

    Which ETFs sold ABBV on Thursday?

    The largest sellers by dollar value were SPY ($48.7 million), XLV ($23.0 million) and IVE ($10.2 million). In all, 40 ETFs added shares and 16 cut them.

    SPY accounted for the largest share of the selling, cutting 165,402 shares for a $48.7 million reduction, with its stake down 0.76% to 21,610,262 shares at a 0.8% weight. XLV shed 78,144 shares worth $23.0 million, trimming its position 0.6% to 13,047,705 shares at a 7.66% weight. IVE sold 34,500 shares for $10.2 million, CGCV cut 19,776 shares for $5.8 million, and IVV reduced 12,312 shares for $3.6 million. AbbVie is a Healthcare company in the Drug Manufacturers – General industry with a market cap of $521.5 billion.

    Have ETFs been buying or selling ABBV lately?

    Over the last 5 reported days, ETFs were net buyers on 2 and net sellers on 3, so the recent trend is mostly selling.

    What does ABBV do?

    AbbVie is a global, diversified research-based biopharmaceutical company that operates as a single segment dedicated to discovering, developing, manufacturing, and commercializing innovative medicines.

    AbbVie reported trailing-12-month revenue of $66.01 billion, up 10.6% over one year, with gross and net margins of 73.7% and 15.7%. Its P/E ratio is 50.78 and its P/S ratio is 7.92. The company has a GF Score of 74, and its GF Value of $229.72 compares with a price of $295.03. AbbVie pays a dividend yield of 2.27% and has returned 32.99% year to date.

    ABBV at a glance



    Source link

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email

    Related Posts

    The Nasdaq Just Entered a Correction. Are Your ETFs All Making the Same Bet?

    November 16, 2026

    ETFs Are Net Sellers of Oracle (ORCL) on Nov. 12

    November 16, 2026

    ETFs Are Buying Palantir (PLTR) on Nov. 12

    November 16, 2026
    Leave A Reply Cancel Reply

    Top Posts

    ETFs Are Net Sellers of AbbVie (ABBV) on Nov. 12

    November 16, 2026

    Is Invesco Diversified Dividend A (LCEAX) a Strong Mutual Fund Pick Right Now?

    November 16, 2026

    The Nasdaq Just Entered a Correction. Are Your ETFs All Making the Same Bet?

    November 16, 2026

    NS&I raises British Savings Bond rates: Three terms above 5%

    October 6, 2026
    Don't Miss
    Mutual Funds

    Is Invesco Diversified Dividend A (LCEAX) a Strong Mutual Fund Pick Right Now?

    November 16, 2026

    Any investors hoping to find a Large Cap Blend fund might consider looking past Invesco…

    Sectoral mutual funds: Should you invest? Risks, returns and 5 things to consider before investing your money

    November 16, 2026

    4 Utilities Mutual Fund Picks to Ride Rising Power Demand

    November 16, 2026

    3 Balanced Mutual Funds to Buy for Long-Term Growth and Stability

    November 16, 2026
    Stay In Touch
    • Facebook
    • Twitter
    • Pinterest
    • Instagram
    • YouTube
    • Vimeo
    EDITOR'S PICK

    ETFs vs NPS: Which Retirement Investment Tool Should You Choose?

    June 8, 2025

    Defiance ETFs Announces First Weekly Distribution of $0.3350/Share for $MST: Defiance Leveraged Long + Income MSTR ETF

    May 19, 2025

    Best Large Cap Mutual Funds: Top 5 schemes that delivered up to 8% returns in one year

    August 6, 2026
    Our Picks

    Is Invesco Diversified Dividend A (LCEAX) a Strong Mutual Fund Pick Right Now?

    November 16, 2026

    Sectoral mutual funds: Should you invest? Risks, returns and 5 things to consider before investing your money

    November 16, 2026

    4 Utilities Mutual Fund Picks to Ride Rising Power Demand

    November 16, 2026
    Most Popular

    🔥Juve target Chukwuemeka, Inter raise funds, Elmas bid in play 🤑

    August 20, 2025

    💵 Libra responds after Flamengo takes legal action and ‘freezes’ funds

    September 26, 2025

    🇮🇸 CPP Investments and Equinix complete atNorth acquisition to support growth of leading Nordic data center platform

    September 1, 2026
    © 2026 Fund Focus News
    • Get In Touch
    • Privacy Policy
    • Terms and Conditions

    Type above and press Enter to search. Press Esc to cancel.